As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
Autolomous and Cellular Origins have announced end-to-end integration of their respective platforms, bringing full autom...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and...
Eppendorf has announced that its Eppendorf Research 3 neo mechanical pipettes have received two major international awar...
Innovative Molecules has dosed the first patient in its Phase 2a clinical trial evaluating adibelivir for recurrent geni...
Sartorius and LFB Biomanufacturing have announced an expansion of their collaboration with the aim of offering biop...
Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...
As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...
WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...
Japanese pharma firm Eisai Co. has announced a strategic investment supported by the UK Government under the Life Scienc...
Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...
CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
MaaT Pharma has presented final Phase 3 data from the ARES pivotal trial evaluating MaaT013 in acute graft-versus-host d...
Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...
Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
